Difference between revisions of "Example orders for Panitumumab (Vectibix) in colon cancer"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.'''" to "<!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.'''-->") |
Warner-admin (talk | contribs) m (Text replacement - " " to " ") |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> |
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 16: | Line 16: | ||
Hydration: | Hydration: | ||
| − | *500 ml NS at KVO rate as running IV for chemotherapy infusion. | + | *500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS. |
Monitoring: | Monitoring: | ||
| − | *Hold if ANC | + | *Hold if ANC less than 1000 or platelets less than 100 and notify physician. |
*Check magnesium prior to each dose of panitumumab | *Check magnesium prior to each dose of panitumumab | ||
[[Category:Example chemotherapy order sets]] | [[Category:Example chemotherapy order sets]] | ||
Latest revision as of 01:53, 1 June 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Panitumumab (Vectibix)
Original references may be found at Panitumumab (Vectibix)
Example regimen #1
- Panitumumab (Vectibix) 6 mg/kg IV over 60 minutes on day 1
- Use 0.22 micron non-DEHP/paclitaxel tubing.
14-day cycles
Hydration:
- 500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS.
Monitoring:
- Hold if ANC less than 1000 or platelets less than 100 and notify physician.
- Check magnesium prior to each dose of panitumumab